Chabiotech Appoints Vice Chairman Chawontae Cha as New CEO

Board Meeting Held on March 4

On March 4, Chabiotech announced that its board of directors held a meeting and appointed Chawontae Cha, Vice Chairman of CHA Medical Center and CHA Bio Group and Chief Sustainability Officer (CSO), as the new CEO.

Chawon Tae, newly appointed CEO of CHA Biotech. CHA Biotech

CEO Cha previously served as Chief Operating Officer (COO) of CHA Health Systems, which operates CHA Hollywood Presbyterian Medical Center in the United States, and as Chief Strategy Officer (CSO) of CHA Hollywood Presbyterian Medical Center. He later served as President of CHA University.

He graduated from the Department of Biological Anatomy at Duke University in the United States. He holds a Master of Public Health (MPH) from Yale University and a Master of Business Administration (MBA) from the Massachusetts Institute of Technology (MIT). He earned a Ph.D. in Public Health from Yonsei University.

Since September last year, CEO Cha has served as Vice Chairman of CHA Medical Center and CHA Bio Group and CSO of Chabiotech, overseeing the establishment of the group’s ESG management system and growth strategies for its affiliates. In January this year, he was appointed as an inside director of Chabiotech to strengthen responsible management.

This content was produced with the assistance of AI translation services.